Genetics Generation Advancement Corp. (4160.TWO)

TWD 64.7

(0.31%)

Total Assets Summary of Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp.'s latest annual total assets in 2023 was 595.05 Million TWD , up 30.59% from previous year.
Genetics Generation Advancement Corp.'s latest quarterly total assets in 2024 Q2 was 790.4 Million TWD , up 33.42% from previous quarter.
Genetics Generation Advancement Corp. reported annual total assets of 455.66 Million TWD in 2022, up 7.28% from previous year.
Genetics Generation Advancement Corp. reported annual total assets of 424.75 Million TWD in 2021, up 3.82% from previous year.
Genetics Generation Advancement Corp. reported quarterly total assets of 790.4 Million TWD for 2024 Q2, up 33.42% from previous quarter.
Genetics Generation Advancement Corp. reported quarterly total assets of 595.05 Million TWD for 2023 FY, up 30.59% from previous quarter.

Annual Total Assets Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Total Assets of Genetics Generation Advancement Corp. (2023 - 2019)

Year	Total Assets	Total Assets Growth
2023	595.05 Million TWD	30.59%
2022	455.66 Million TWD	7.28%
2021	424.75 Million TWD	3.82%
2020	409.13 Million TWD	-7.09%
2019	440.34 Million TWD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	592.42 Million TWD	-0.44%
2024 Q2	790.4 Million TWD	33.42%
2023 FY	595.05 Million TWD	30.59%
2023 Q4	595.05 Million TWD	8.34%
2023 Q3	549.25 Million TWD	0.19%
2023 Q2	548.23 Million TWD	17.77%
2023 Q1	465.5 Million TWD	0.0%
2022 Q4	- TWD	0.0%
2022 FY	455.66 Million TWD	7.28%
2021 FY	424.75 Million TWD	3.82%
2020 FY	409.13 Million TWD	0.0%

Peer Total Assets Comparison of Genetics Generation Advancement Corp.

Name	Total Assets	Total Assets Difference
BIONET Corp.	2.34 Billion TWD	74.664%
DIVA Laboratories, Ltd.	1.24 Billion TWD	52.156%
Welgene Biotech Co.,Ltd.	548.16 Million TWD	-8.554%
Puriblood Medical Co., Ltd.	265.51 Million TWD	-124.115%
TFBS Bioscience Inc.	1.44 Billion TWD	58.906%